APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Digital Pathology Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digital Pathology Software Market Outlook and Growth Opportunities 2026

Report ID 174506550412 August 2026211 pages

Choose your research edition.

Industry ResearchDigital Pathology Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Pathology Software Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Digital Pathology Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Pathology Software Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Pathology Software Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Digital Pathology Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digital Pathology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digital Pathology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Pathology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digital Pathology Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digital Pathology Software market include Roche, 3DHISTECH, Hamamatsu Photonics, ZEISS, OptraScan, Media Cyber​​netics, Visiopharm, Sectra and Digital Slide Archive, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Digital Pathology Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digital Pathology Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digital Pathology Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digital Pathology Software market.

Digital Pathology Software Segment by Company

Roche

3DHISTECH

Hamamatsu Photonics

ZEISS

OptraScan

Media Cyber​​netics

Visiopharm

Sectra

Digital Slide Archive

Aiforia

PathAI

Pathomation

Proscia

Indica Labs

Gestalt

Xybion

NovoPath

Glencoe Software

Orbit Image Analysis

Augmentiqs

Leica Biosystems

Olympus

Philips

Digital Pathology Software Segment by Type

Open-Source Platforms

Closed-Source Platforms

Digital Pathology Software Segment by Application

Pharmaceutical

Clinical Use

Research

Education

Digital Pathology Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Digital Pathology Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Digital Pathology Software key companies, revenue, market share, and recent developments.

3. To split the Digital Pathology Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Digital Pathology Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digital Pathology Software significant trends, drivers, influence factors in global and regions.

6. To analyze Digital Pathology Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Pathology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Pathology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Pathology Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Pathology Software industry.

Chapter 3: Detailed analysis of Digital Pathology Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Digital Pathology Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Digital Pathology Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digital Pathology Software Industry Trends Table 2. Digital Pathology Software Industry Drivers Table 3. Digital Pathology Software Industry Opportunities and Challenges Table 4. Digital Pathology Software Industry Restraints Table 5. Global Digital Pathology Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digital Pathology Software Revenue Share by Company (2021-2026) Table 7. Global Digital Pathology Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Digital Pathology Software Key Company Manufacturing Base & Headquarters Table 9. Global Digital Pathology Software Company, Product Type & Application Table 10. Global Digital Pathology Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Digital Pathology Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Open-Source Platforms Table 15. Significant Companies of Closed-Source Platforms Table 16. Global Digital Pathology Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Digital Pathology Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Digital Pathology Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Digital Pathology Software Sales Value Share by Type (2021-2026) Table 20. Global Digital Pathology Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical Table 22. Significant Companies of Clinical Use Table 23. Significant Companies of Research Table 24. Significant Companies of Education Table 25. Global Digital Pathology Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Digital Pathology Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Digital Pathology Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Digital Pathology Software Sales Value Share by Application (2021-2026) Table 29. Global Digital Pathology Software Sales Value Share by Application (2027-2032) Table 30. Global Digital Pathology Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Digital Pathology Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Digital Pathology Software Sales Value Share by Region (2021-2026) Table 33. Global Digital Pathology Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Digital Pathology Software Sales Value Share by Region (2027-2032) Table 35. Global Digital Pathology Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Digital Pathology Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Digital Pathology Software Sales Value Market Share by Country (2021-2026) Table 38. Global Digital Pathology Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Digital Pathology Software Sales Value Market Share by Country (2027-2032) Table 40. Roche Company Information Table 41. Roche Business Overview Table 42. Roche Digital Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Roche Digital Pathology Software Product Portfolio Table 44. Roche Recent Development Table 45. 3DHISTECH Company Information Table 46. 3DHISTECH Business Overview Table 47. 3DHISTECH Digital Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. 3DHISTECH Digital Pathology Software Product Portfolio Table 49. 3DHISTECH Recent Development Table 50. Hamamatsu Photonics Company Information Table 51. Hamamatsu Photonics Business Overview Table 52. Hamamatsu Photonics Digital Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Hamamatsu Photonics Digital Pathology Software Product Portfolio Table 54. Hamamatsu Photonics Recent Development Table 55. ZEISS Company Information Table 56. ZEISS Business Overview Table 57. ZEISS Digital Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. ZEISS Digital Pathology Software Product Portfolio Table 59. ZEISS Recent Development Table 60. OptraScan Company Information Table 61. OptraScan Business Overview Table 62. OptraScan Digital Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. OptraScan Digital Pathology Software Product Portfolio Table 64. OptraScan Recent Development Table 65. Media Cyber​​netics Company Information Table 66. Media Cyber​​netics Business Overview Table 67. Media Cyber​​netics Digital Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Media Cyber​​netics Digital Pathology Software Product Portfolio Table 69. Media Cyber​​netics Recent Development Table 70. Visiopharm Company Information Table 71. Visiopharm Business Overview Table 72. Visiopharm Digital Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Visiopharm Digital Pathology Software Product Portfolio Table 74. Visiopharm Recent Development Table 75. Sectra Company Information Table 76. Sectra Business Overview Table 77. Sectra Digital Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sectra Digital Pathology Software Product Portfolio Table 79. Sectra Recent Development Table 80. Digital Slide Archive Company Information Table 81. Digital Slide Archive Business Overview Table 82. Digital Slide Archive Digital Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Digital Slide Archive Digital Pathology Software Product Portfolio Table 84. Digital Slide Archive Recent Development Table 85. Aiforia Company Information Table 86. Aiforia Business Overview Table 87. Aiforia Digital Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Aiforia Digital Pathology Software Product Portfolio Table 89. Aiforia Recent Development Table 90. PathAI Company Information Table 91. PathAI Business Overview Table 92. PathAI Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. PathAI Digital Pathology Software Product Portfolio Table 94. PathAI Recent Development Table 95. Pathomation Company Information Table 96. Pathomation Business Overview Table 97. Pathomation Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Pathomation Digital Pathology Software Product Portfolio Table 99. Pathomation Recent Development Table 100. Proscia Company Information Table 101. Proscia Business Overview Table 102. Proscia Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Proscia Digital Pathology Software Product Portfolio Table 104. Proscia Recent Development Table 105. Indica Labs Company Information Table 106. Indica Labs Business Overview Table 107. Indica Labs Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Indica Labs Digital Pathology Software Product Portfolio Table 109. Indica Labs Recent Development Table 110. Gestalt Company Information Table 111. Gestalt Business Overview Table 112. Gestalt Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Gestalt Digital Pathology Software Product Portfolio Table 114. Gestalt Recent Development Table 115. Xybion Company Information Table 116. Xybion Business Overview Table 117. Xybion Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Xybion Digital Pathology Software Product Portfolio Table 119. Xybion Recent Development Table 120. NovoPath Company Information Table 121. NovoPath Business Overview Table 122. NovoPath Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. NovoPath Digital Pathology Software Product Portfolio Table 124. NovoPath Recent Development Table 125. Glencoe Software Company Information Table 126. Glencoe Software Business Overview Table 127. Glencoe Software Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Glencoe Software Digital Pathology Software Product Portfolio Table 129. Glencoe Software Recent Development Table 130. Orbit Image Analysis Company Information Table 131. Orbit Image Analysis Business Overview Table 132. Orbit Image Analysis Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Orbit Image Analysis Digital Pathology Software Product Portfolio Table 134. Orbit Image Analysis Recent Development Table 135. Augmentiqs Company Information Table 136. Augmentiqs Business Overview Table 137. Augmentiqs Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Augmentiqs Digital Pathology Software Product Portfolio Table 139. Augmentiqs Recent Development Table 140. Leica Biosystems Company Information Table 141. Leica Biosystems Business Overview Table 142. Leica Biosystems Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Leica Biosystems Digital Pathology Software Product Portfolio Table 144. Leica Biosystems Recent Development Table 145. Olympus Company Information Table 146. Olympus Business Overview Table 147. Olympus Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Olympus Digital Pathology Software Product Portfolio Table 149. Olympus Recent Development Table 150. Philips Company Information Table 151. Philips Business Overview Table 152. Philips Digital Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Philips Digital Pathology Software Product Portfolio Table 154. Philips Recent Development Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Digital Pathology Software Product Image Figure 2. Global Digital Pathology Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Pathology Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Digital Pathology Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Open-Source Platforms Image Figure 8. Closed-Source Platforms Image Figure 9. Global Digital Pathology Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Digital Pathology Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Digital Pathology Software Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical Image Figure 13. Clinical Use Image Figure 14. Research Image Figure 15. Education Image Figure 16. Global Digital Pathology Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Digital Pathology Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Digital Pathology Software Sales Value Share by Application (2021-2032) Figure 19. Global Digital Pathology Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Digital Pathology Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Digital Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Digital Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Digital Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Digital Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Digital Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Digital Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Digital Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Digital Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Digital Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Digital Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Digital Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Digital Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Digital Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Open-Source Platforms
  • Closed-Source Platforms
Applications
  • Pharmaceutical
  • Clinical Use
  • Research
  • Education
Companies covered
  • Roche
  • 3DHISTECH
  • Hamamatsu Photonics
  • ZEISS
  • OptraScan
  • Media Cyber​​netics
  • Visiopharm
  • Sectra
  • Digital Slide Archive
  • Aiforia
  • PathAI
  • Pathomation
  • Proscia
  • Indica Labs
  • Gestalt
  • Xybion
  • NovoPath
  • Glencoe Software
  • Orbit Image Analysis
  • Augmentiqs
  • Leica Biosystems
  • Olympus
  • Philips

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digital Pathology Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digital Pathology Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Digital Pathology Software Market Dynamics
  1. 2.1 Digital Pathology Software Industry Trends
  2. 2.2 Digital Pathology Software Industry Drivers
  3. 2.3 Digital Pathology Software Industry Opportunities and Challenges
  4. 2.4 Digital Pathology Software Industry Restraints
3 Digital Pathology Software Market by Company
  1. 3.1 Global Digital Pathology Software Company Revenue Ranking in 2025
  2. 3.2 Global Digital Pathology Software Revenue by Company (2021-2026)
  3. 3.3 Global Digital Pathology Software Company Ranking (2024-2026)
  4. 3.4 Global Digital Pathology Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Digital Pathology Software Company Product Type and Application
  6. 3.6 Global Digital Pathology Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Digital Pathology Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Digital Pathology Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Digital Pathology Software Market by Type
  1. 4.1 Digital Pathology Software Type Introduction
  2. 4.1.1 Open-Source Platforms
  3. 4.1.2 Closed-Source Platforms
  4. 4.2 Global Digital Pathology Software Sales Value by Type
  5. 4.2.1 Global Digital Pathology Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Digital Pathology Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Digital Pathology Software Sales Value Share by Type (2021-2032)
5 Digital Pathology Software Market by Application
  1. 5.1 Digital Pathology Software Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Clinical Use
  4. 5.1.3 Research
  5. 5.1.4 Education
  6. 5.2 Global Digital Pathology Software Sales Value by Application
  7. 5.2.1 Global Digital Pathology Software Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Digital Pathology Software Sales Value by Application (2021-2032)
  9. 5.2.3 Global Digital Pathology Software Sales Value Share by Application (2021-2032)
6 Digital Pathology Software Regional Value Analysis
  1. 6.1 Global Digital Pathology Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digital Pathology Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Digital Pathology Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Digital Pathology Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digital Pathology Software Sales Value (2021-2032)
  7. 6.3.2 North America Digital Pathology Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Digital Pathology Software Sales Value (2021-2032)
  10. 6.4.2 Europe Digital Pathology Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Digital Pathology Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Digital Pathology Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Digital Pathology Software Sales Value (2021-2032)
  16. 6.6.2 South America Digital Pathology Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Digital Pathology Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Digital Pathology Software Sales Value Share by Country, 2025 VS 2032
7 Digital Pathology Software Country-level Value Analysis
  1. 7.1 Global Digital Pathology Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digital Pathology Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Digital Pathology Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Digital Pathology Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Digital Pathology Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Digital Pathology Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Digital Pathology Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Digital Pathology Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Digital Pathology Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Digital Pathology Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Digital Pathology Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Digital Pathology Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Digital Pathology Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Digital Pathology Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Digital Pathology Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Digital Pathology Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Digital Pathology Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Digital Pathology Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Digital Pathology Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Digital Pathology Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Digital Pathology Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Digital Pathology Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Digital Pathology Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Digital Pathology Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Digital Pathology Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Digital Pathology Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Digital Pathology Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Digital Pathology Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Digital Pathology Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Digital Pathology Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Digital Pathology Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Digital Pathology Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Digital Pathology Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Digital Pathology Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Digital Pathology Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Digital Pathology Software Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 3DHISTECH
  8. 8.2.1 3DHISTECH Company Information
  9. 8.2.2 3DHISTECH Business Overview
  10. 8.2.3 3DHISTECH Digital Pathology Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 3DHISTECH Digital Pathology Software Product Portfolio
  12. 8.2.5 3DHISTECH Recent Developments
  13. 8.3 Hamamatsu Photonics
  14. 8.3.1 Hamamatsu Photonics Company Information
  15. 8.3.2 Hamamatsu Photonics Business Overview
  16. 8.3.3 Hamamatsu Photonics Digital Pathology Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hamamatsu Photonics Digital Pathology Software Product Portfolio
  18. 8.3.5 Hamamatsu Photonics Recent Developments
  19. 8.4 ZEISS
  20. 8.4.1 ZEISS Company Information
  21. 8.4.2 ZEISS Business Overview
  22. 8.4.3 ZEISS Digital Pathology Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ZEISS Digital Pathology Software Product Portfolio
  24. 8.4.5 ZEISS Recent Developments
  25. 8.5 OptraScan
  26. 8.5.1 OptraScan Company Information
  27. 8.5.2 OptraScan Business Overview
  28. 8.5.3 OptraScan Digital Pathology Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 OptraScan Digital Pathology Software Product Portfolio
  30. 8.5.5 OptraScan Recent Developments
  31. 8.6 Media Cyber​​netics
  32. 8.6.1 Media Cyber​​netics Company Information
  33. 8.6.2 Media Cyber​​netics Business Overview
  34. 8.6.3 Media Cyber​​netics Digital Pathology Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Media Cyber​​netics Digital Pathology Software Product Portfolio
  36. 8.6.5 Media Cyber​​netics Recent Developments
  37. 8.7 Visiopharm
  38. 8.7.1 Visiopharm Company Information
  39. 8.7.2 Visiopharm Business Overview
  40. 8.7.3 Visiopharm Digital Pathology Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Visiopharm Digital Pathology Software Product Portfolio
  42. 8.7.5 Visiopharm Recent Developments
  43. 8.8 Sectra
  44. 8.8.1 Sectra Company Information
  45. 8.8.2 Sectra Business Overview
  46. 8.8.3 Sectra Digital Pathology Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sectra Digital Pathology Software Product Portfolio
  48. 8.8.5 Sectra Recent Developments
  49. 8.9 Digital Slide Archive
  50. 8.9.1 Digital Slide Archive Company Information
  51. 8.9.2 Digital Slide Archive Business Overview
  52. 8.9.3 Digital Slide Archive Digital Pathology Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Digital Slide Archive Digital Pathology Software Product Portfolio
  54. 8.9.5 Digital Slide Archive Recent Developments
  55. 8.10 Aiforia
  56. 8.10.1 Aiforia Company Information
  57. 8.10.2 Aiforia Business Overview
  58. 8.10.3 Aiforia Digital Pathology Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aiforia Digital Pathology Software Product Portfolio
  60. 8.10.5 Aiforia Recent Developments
  61. 8.11 PathAI
  62. 8.11.1 PathAI Company Information
  63. 8.11.2 PathAI Business Overview
  64. 8.11.3 PathAI Digital Pathology Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 PathAI Digital Pathology Software Product Portfolio
  66. 8.11.5 PathAI Recent Developments
  67. 8.12 Pathomation
  68. 8.12.1 Pathomation Company Information
  69. 8.12.2 Pathomation Business Overview
  70. 8.12.3 Pathomation Digital Pathology Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pathomation Digital Pathology Software Product Portfolio
  72. 8.12.5 Pathomation Recent Developments
  73. 8.13 Proscia
  74. 8.13.1 Proscia Company Information
  75. 8.13.2 Proscia Business Overview
  76. 8.13.3 Proscia Digital Pathology Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Proscia Digital Pathology Software Product Portfolio
  78. 8.13.5 Proscia Recent Developments
  79. 8.14 Indica Labs
  80. 8.14.1 Indica Labs Company Information
  81. 8.14.2 Indica Labs Business Overview
  82. 8.14.3 Indica Labs Digital Pathology Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Indica Labs Digital Pathology Software Product Portfolio
  84. 8.14.5 Indica Labs Recent Developments
  85. 8.15 Gestalt
  86. 8.15.1 Gestalt Company Information
  87. 8.15.2 Gestalt Business Overview
  88. 8.15.3 Gestalt Digital Pathology Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Gestalt Digital Pathology Software Product Portfolio
  90. 8.15.5 Gestalt Recent Developments
  91. 8.16 Xybion
  92. 8.16.1 Xybion Company Information
  93. 8.16.2 Xybion Business Overview
  94. 8.16.3 Xybion Digital Pathology Software Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Xybion Digital Pathology Software Product Portfolio
  96. 8.16.5 Xybion Recent Developments
  97. 8.17 NovoPath
  98. 8.17.1 NovoPath Company Information
  99. 8.17.2 NovoPath Business Overview
  100. 8.17.3 NovoPath Digital Pathology Software Revenue and Gross Margin (2021-2026)
  101. 8.17.4 NovoPath Digital Pathology Software Product Portfolio
  102. 8.17.5 NovoPath Recent Developments
  103. 8.18 Glencoe Software
  104. 8.18.1 Glencoe Software Company Information
  105. 8.18.2 Glencoe Software Business Overview
  106. 8.18.3 Glencoe Software Digital Pathology Software Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Glencoe Software Digital Pathology Software Product Portfolio
  108. 8.18.5 Glencoe Software Recent Developments
  109. 8.19 Orbit Image Analysis
  110. 8.19.1 Orbit Image Analysis Company Information
  111. 8.19.2 Orbit Image Analysis Business Overview
  112. 8.19.3 Orbit Image Analysis Digital Pathology Software Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Orbit Image Analysis Digital Pathology Software Product Portfolio
  114. 8.19.5 Orbit Image Analysis Recent Developments
  115. 8.20 Augmentiqs
  116. 8.20.1 Augmentiqs Company Information
  117. 8.20.2 Augmentiqs Business Overview
  118. 8.20.3 Augmentiqs Digital Pathology Software Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Augmentiqs Digital Pathology Software Product Portfolio
  120. 8.20.5 Augmentiqs Recent Developments
  121. 8.21 Leica Biosystems
  122. 8.21.1 Leica Biosystems Company Information
  123. 8.21.2 Leica Biosystems Business Overview
  124. 8.21.3 Leica Biosystems Digital Pathology Software Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Leica Biosystems Digital Pathology Software Product Portfolio
  126. 8.21.5 Leica Biosystems Recent Developments
  127. 8.22 Olympus
  128. 8.22.1 Olympus Company Information
  129. 8.22.2 Olympus Business Overview
  130. 8.22.3 Olympus Digital Pathology Software Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Olympus Digital Pathology Software Product Portfolio
  132. 8.22.5 Olympus Recent Developments
  133. 8.23 Philips
  134. 8.23.1 Philips Company Information
  135. 8.23.2 Philips Business Overview
  136. 8.23.3 Philips Digital Pathology Software Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Philips Digital Pathology Software Product Portfolio
  138. 8.23.5 Philips Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst